Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 Xinsongjiang Road, Songjiang District, Shanghai, 201620, China.
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Exp Clin Cancer Res. 2019 Nov 9;38(1):461. doi: 10.1186/s13046-019-1423-5.
Tumor cell repopulation after radiotherapy is a major cause for the tumor radioresistance and recurrence. This study aims to investigate the underlying mechanism of tumor repopulation after radiotherapy, with focus on whether and how necroptosis takes part in this process.
Necroptosis after irradiation were examined in vitro and in vivo. And the growth-promoting effect of necroptotic cells was investigated by chemical inhibitors or shRNA against necroptosis associated proteins and genes in in vitro and in vivo tumor repopulation models. Downstream relevance factors of necroptosis were identified by western blot and chemiluminescent immunoassays. Finally, the immunohistochemistry staining of identified necroptosis association growth stimulation factor was conducted in human colorectal tumor specimens to verify the relationship with clinical outcome.
Radiation-induced necroptosis depended on activation of RIP1/RIP3/MLKL pathway, and the evidence in vitro and in vivo demonstrated that the inhibition of necroptosis attenuated growth-stimulating effects of irradiated tumor cells on living tumor reporter cells. The JNK/IL-8 were identified as downstream molecules of pMLKL during necroptosis, and inhibition of JNK, IL-8 or IL-8 receptor significantly reduced tumor repopulation after radiotherapy. Moreover, the high expression of IL-8 was associated with poor clinical prognosis in colorectal cancer patients.
Necroptosis associated tumor repopulation after radiotherapy depended on activation of RIP1/RIP3/MLKL/JNK/IL-8 pathway. This novel pathway provided new insight into understanding the mechanism of tumor radioresistance and repopulation, and MLKL/JNK/IL-8 could be developed as promising targets for blocking tumor repopulation to enhance the efficacy of colorectal cancer radiotherapy.
肿瘤细胞在放疗后的再增殖是肿瘤放射抵抗和复发的主要原因。本研究旨在探讨放疗后肿瘤再增殖的潜在机制,重点研究坏死性细胞死亡是否以及如何参与这一过程。
在体外和体内研究照射后的细胞坏死性细胞死亡。通过化学抑制剂或针对坏死性细胞死亡相关蛋白和基因的 shRNA,在体外和体内肿瘤再增殖模型中研究坏死性细胞的促生长作用。通过 Western blot 和化学发光免疫测定法鉴定坏死性细胞死亡的下游相关因素。最后,对人结直肠肿瘤标本进行鉴定的坏死性细胞死亡相关生长刺激因子的免疫组织化学染色,以验证与临床结果的关系。
辐射诱导的坏死性细胞死亡依赖于 RIP1/RIP3/MLKL 通路的激活,体外和体内的证据表明,抑制坏死性细胞死亡可减弱照射肿瘤细胞对活肿瘤报告细胞的生长刺激作用。在坏死性细胞死亡过程中,JNK/IL-8 被鉴定为 pMLKL 的下游分子,抑制 JNK、IL-8 或 IL-8 受体可显著减少放疗后的肿瘤再增殖。此外,IL-8 的高表达与结直肠癌患者的不良临床预后相关。
放疗后与坏死性细胞死亡相关的肿瘤再增殖依赖于 RIP1/RIP3/MLKL/JNK/IL-8 通路的激活。这条新途径为理解肿瘤放射抵抗和再增殖的机制提供了新的见解,MLKL/JNK/IL-8 可作为阻断肿瘤再增殖以增强结直肠癌放疗疗效的有前途的靶点。